Skip to content

IP Policy

About our IP Policy.

About our IP Policy

Update 3.0: This policy was updated on 24 June 2019. Any plasmid or DNA product purchased before this date is subject to the terms of the previous version of this document which is available on request by contacting:

Our IP Policy

We are the owner or the licensee of all intellectual property rights in the products sold by us, other than in nucleic acid sequences supplied by our customers. If you purchase any of our products, we will grant you a non-exclusive, non-transferable, limited licence to use them solely for the permitted purposes as defined in the applicable limited use label licence or licences (LULL) and not for any other purpose.

To view the SnapFast™ and SnapFast™ Pro Plasmid Limited Use Label Licence please click here.

Third Party IP Policy

Our products have been constructed with a view to avoiding pre-existing intellectual property rights belonging to 3rd parties (with a few notable exceptions that will be highlighted where possible on each product page). Where no comments have been added to a product page, we have typically searched worldwide patent databases and have not found any issued patents or published patent applications with claims relating to the sequences within the products.

Nevertheless, Oxford Genetics cannot warrant that such intellectual property rights do not exist, or that the use of our products may not infringe a method-related patent where applicable. Therefore, purchasers should perform their own assessments of the relevant IP field.

By purchasing our products, you acknowledge that use of our products may be claimed to infringe the intellectual property rights of third parties and that we give no indemnity for any such alleged or actual infringement.


Sometimes we incorporate in our products nucleic acid sequences, or use methods in the manufacture of our products, that are licensed to us from other companies, and when those companies impose restrictions we are obliged to pass them on. At the present time, such restrictions apply to only a few of our plasmid products in specific territories and to products made using CRISPR Cas9 technology. The intellectual property status of each product is indicated in the corresponding product page.


By purchasing any Oxford Genetics product, you represent and warrant that you have obtained all third-party licences and rights, including all patent and intellectual property rights, necessary for your intended use of the Oxford Genetics product.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of qualify control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.